Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ENSAT Stage I Adrenal Cortex Carcinoma × Dichlorodiphenyldichloroethane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Adrenocortical Carcinoma 2 ENSAT Stage I Adrenal Cortex Carcinoma 1

Interventions

Platinum 1 Mitotane 1 Etoposide 1 Ethane 1 Dichlorodiphenyldichloroethane 1 Cisplatin 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03583710 2026-04-07

Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

M.D. Anderson Cancer Center

Phase 3 Recruiting

ENSAT Stage I Adrenal Cortex Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡